• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)对心肌去表皮纤维细肌束的作用。

The effect of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), on thin bundles of skinned fibers from cardiac muscle.

作者信息

Endo M

出版信息

Arzneimittelforschung. 1984;34(3A):380-3.

PMID:6540092
Abstract

The effect of 3, 4-dihydro-6-[4-(3,4- dimethoxybenzoyl )-1-piperazinyl]-2(1H)- quin olinone ( OPC -8212), a new positive inotropic agent, on the contractile system and the sarcoplasmic reticulum (SR) was examined by using thin bundles of chemically skinned fibers from ventricular trabeculae of the guinea pig and the African clawed toad. Sulfolane , the solvent of OPC -8212 used in the present experiments, slightly increased the Ca-sensitivity of the contractile system of cardiac skinned fibers, and decreased the maximum tension developed at high enough concentrations of Ca. OPC -8212 up to 300 mumol/l did not add any further effects. Initial rate of Ca uptake by the SR was not affected by 300 mummol /l OPC -8212 plus 0.6% sulfolane . The Ca-sensitivity of the Ca-induced Ca release mechanism in the SR was increased by 0.6% sulfolane but no further effect was observed by an addition of OPC -8212 up to 300 mumol/l. Thus, no direct effect of 300 mumol/l OPC -8212 per se was found on the contractile system or the SR. In view of these findings, the mechanism of positive inotropic action of OPC -8212 was discussed.

摘要

新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)对收缩系统和肌浆网(SR)的影响,采用豚鼠和非洲爪蟾心室小梁化学去皮纤维细束进行了研究。本实验中使用的OPC-8212的溶剂环丁砜,略微增加了心脏去皮纤维收缩系统的钙敏感性,并在足够高的钙浓度下降低了产生的最大张力。高达300μmol/l的OPC-8212没有产生任何进一步的影响。300μmol/l的OPC-8212加0.6%环丁砜对SR摄取钙的初始速率没有影响。SR中钙诱导钙释放机制的钙敏感性被0.6%环丁砜增加,但加入高达300μmol/l的OPC-8212未观察到进一步影响。因此,未发现300μmol/l的OPC-8212本身对收缩系统或SR有直接影响。鉴于这些发现,对OPC-8212的正性肌力作用机制进行了讨论。

相似文献

1
The effect of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), on thin bundles of skinned fibers from cardiac muscle.一种新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)对心肌去表皮纤维细肌束的作用。
Arzneimittelforschung. 1984;34(3A):380-3.
2
Effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212) and its solvent sulfolane on isolated heart preparations of the rat, guinea pig, and dog.一种新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)及其溶剂环丁砜对大鼠、豚鼠和犬离体心脏标本的影响。
Arzneimittelforschung. 1984;34(3A):359-63.
3
Studies on the mechanism of action of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), a new positive inotropic drug. Enzyme activities and Ca2+ transport processes of sarcolemma and intracellular organelles.新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)的作用机制研究。肌膜和细胞内细胞器的酶活性及Ca2+转运过程。
Arzneimittelforschung. 1984;34(3A):384-9.
4
Electro-mechanical effects of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), a new positive inotropic agent. Isolated adult canine Purkinje strands and ventricular trabeculae.
Arzneimittelforschung. 1984;34(3A):371-5.
5
Increase in Ca++ sensitivity of the contractile system by MCI-154, a novel cardiotonic agent, in chemically skinned fibers from the guinea pig papillary muscles.新型强心剂MCI - 154对豚鼠乳头肌化学去膜纤维收缩系统Ca++敏感性的增强作用。
J Pharmacol Exp Ther. 1987 Nov;243(2):633-8.
6
In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)在多种动物体内和体外的研究。
Arzneimittelforschung. 1984;34(3A):342-6.
7
Positive inotropic effect of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1 -piperazinyl]-2(1H)-quinolinone (OPC-8212) and mechanism of action in guinea pig ventricular myocardium.3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)对豚鼠心室肌的正性肌力作用及其作用机制
Arzneimittelforschung. 1984;34(3A):364-70.
8
Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)对实验性诱导的犬右侧心力衰竭的正性肌力作用。
Arzneimittelforschung. 1984;34(3A):390-3.
9
Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart.新型正性肌力药物3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)对犬心脏的作用方式及作用机制
Arzneimittelforschung. 1984;34(3A):347-55.
10
Effects of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl] -2(1H)-quinolinone (OPC-8212), a new inotropic agent, on cardiotonic activity and coronary hemodynamics.新型强心剂3,4-二氢-6-[4-(3,4-二甲氧基苯甲酰基)-1-哌嗪基]-2(1H)-喹啉酮(OPC-8212)对强心活性和冠状动脉血流动力学的影响。
Arzneimittelforschung. 1984;34(3A):355-9.

引用本文的文献

1
Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.新型正性肌力药物OPC-8212对严重充血性心力衰竭的急性血流动力学效应
Heart Vessels. 1986;2(1):23-8. doi: 10.1007/BF02060240.
2
A new cardiotonic agent, OPC-8212, elevates the myocardial oxygen consumption versus pressure-volume area (PVA) relation in a similar manner to catecholamines and calcium in canine hearts.一种新型强心剂OPC - 8212,以与儿茶酚胺和钙类似的方式提高犬心脏中与压力-容积面积(PVA)相关的心肌耗氧量。
Heart Vessels. 1988;4(3):153-61. doi: 10.1007/BF02058428.
3
Cyclic AMP-dependent and cyclic AMP-independent actions of a novel cardiotonic agent, OPC-8212.
新型强心剂OPC-8212的环磷酸腺苷依赖性和非环磷酸腺苷依赖性作用
Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):692-8. doi: 10.1007/BF00165636.
4
A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failure. OPC-8212 Multicenter Research Group.OPC-8212治疗轻度慢性心力衰竭患者的安慰剂对照、随机、双盲研究。OPC-8212多中心研究组
Cardiovasc Drugs Ther. 1990 Apr;4(2):419-25. doi: 10.1007/BF01857748.